Polycystic kidney disease trials in China

4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Early phase 1Not yet taking people in China
  GBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease

  Where

  Shanghai

  Age

  18 years to 65 years

  People

  24

  Run by

  RenJi Hospital

  See details and how to joinNCT07891364
• Phase 1Taking people
  Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

  Where

  Chengdu, Hangzhou, Nanjing, Shanghai, Wuhan, Xiamen

  Age

  18 years to 65 years

  People

  40 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07228364
• Phase 2Taking people
  Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  Where

  Beijing

  Age

  18 years to 55 years

  People

  135

  Run by

  Jemincare

  See details and how to joinNCT06800651
• No phaseEnrolling by invitation
  The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease

  Where

  Beijing

  Age

  18 years to 80 years

  People

  30

  Run by

  Peking University First Hospital

  See details and how to joinNCT06841224